Your joints are stiff, and your genes may be why.

COL1A1 encodes collagen type I, the primary structural protein in your tendons, ligaments, and bone matrix. Think of it as the scaffolding that gives your joints their shape and strength. Your body produces collagen constantly, and COL1A1 determines how well that collagen is made and cross-linked together.

The rs1800012 Sp1 site variant in COL1A1, carried by roughly 15-20% of the population, disrupts the normal cross-linking of collagen fibers. This creates weaker, more fragile connective tissue that simply cannot maintain the same structural integrity as normal collagen. Your joints have less tensile strength, and your ligaments are more lax.

For you, this feels like stiffness paired with a sense that your joints lack stability. Your knees might feel like they could buckle. Your shoulders feel loose but tight at the same time. Stretching doesn’t help because the problem isn’t tightness of muscle; it’s weakened collagen that your nervous system is guarding against by holding tension.

IL6 produces interleukin-6, a cytokine that regulates inflammation throughout your body. In healthy amounts, IL-6 helps with recovery and immune function. But certain variants shift your baseline IL-6 production higher, creating a chronic low-grade inflammatory state.

The -174G>C variant (rs1800795), present in roughly 40% of people, increases IL-6 expression. Higher IL-6 activates the RANKL pathway, which triggers osteoclasts to break down bone and cartilage faster than osteoblasts can rebuild it. This tilts the balance from joint maintenance to joint degradation. Your body is literally breaking down cartilage and bone tissue more aggressively than it should.

You experience this as morning stiffness that takes an hour or more to resolve, pain and stiffness after inactivity, and a general sense that your joints feel inflamed even though standard inflammatory markers (CRP, ESR) come back normal. Your stiffness is driven by chronic, gene-mediated inflammation that blood tests don’t capture.

TNF produces tumor necrosis factor-alpha, a master regulator of inflammation. High TNF levels activate both osteoclasts (cells that break down bone) and inflammatory pathways that drive arthritis. TNF also suppresses bone formation, so you get a double hit: faster bone loss and slower bone building.

The -308G>A variant (rs1800629), carried by roughly 30% of the population, increases TNF production. This creates a proinflammatory state that accelerates osteoclast activity and drives inflammatory arthritis progression. Your joints aren’t just stiff; they’re in an actively degrading inflammatory environment. This variant is strongly associated with rheumatoid arthritis, but even in people without RA, it creates baseline joint inflammation.

For you, this shows up as joint stiffness that worsens with stress or during inflammatory flares, pain that feels deep in the joint rather than muscular, and the sense that your joints are angry rather than just tight. Many people with TNF variants find that emotional stress directly triggers joint pain and stiffness.

VDR encodes the vitamin D receptor, the key that lets vitamin D unlock calcium absorption in your intestines and regulate bone mineralization. Without proper VDR function, you cannot absorb enough calcium, and your bones become progressively weaker and more brittle. This directly affects joint stability and, consequently, joint stiffness.

VDR variants (BsmI, FokI, TaqI), present in roughly 30-50% of the population depending on ancestry, reduce receptor sensitivity and calcium absorption efficiency. This means you can take calcium supplements and get adequate sun exposure and still remain functionally calcium-depleted at the cellular level. Your bones become less dense, your joints become less stable, and your nervous system responds by creating muscular tension to compensate.

You experience this as stiffness that improves temporarily with heat (which relaxes muscles) but returns, a sense that your bones feel weak or brittle, and often, a pattern of worsening stiffness in winter (lower vitamin D) or improvement after sun exposure. Your joints are literally losing mineral density, making them more prone to inflammation and stiffness.

COL11A1 encodes collagen type XI, a critical structural protein in cartilage. Unlike COL1A1 (which is mostly bone and tendon), COL11A1 specifically maintains the extracellular matrix of cartilage. It keeps cartilage elastic, hydrated, and resilient. When COL11A1 variants are present, the cartilage matrix becomes fragile and degrades faster.

Variants in COL11A1, found in roughly 20-30% of the population, reduce cartilage matrix integrity and accelerate early osteoarthritis. Your cartilage becomes stiff, loses its shock-absorbing capacity, and begins to break down earlier than it should, leading to joint stiffness and pain that can appear in your 30s or 40s rather than your 60s. This gene is also associated with joint hypermobility in some variants, which paradoxically also causes stiffness as your body guards against excess movement.

You notice this as progressive morning stiffness in specific joints (knees, hips, shoulders), a feeling that your joints lack cushioning, pain with weight-bearing activities that improves with rest, and a general sense that your joints are aging faster than the rest of your body. The stiffness is real cartilage loss, not just inflammation or muscular tightness.

GDF5 produces growth differentiation factor 5, a protein that shapes joint structure, cartilage growth, and joint morphology. It determines how your joints are literally built. GDF5 is active not only during development but throughout your life, continuously influencing joint health and cartilage maintenance. When GDF5 expression is reduced, your joints develop suboptimally and degrade faster.

The rs143384 variant, carried by roughly 40% of the population, reduces GDF5 expression. This variant is strongly associated with osteoarthritis susceptibility, particularly in weight-bearing joints like the knee and hip. Your joints were literally shaped slightly differently during development, with slightly less cartilage volume and slightly less joint space, making them more vulnerable to mechanical stress and earlier degeneration.

For you, this manifests as progressive stiffness in specific joints that bear weight or see repetitive use, a feeling that your joint structure is just slightly wrong (tight in ways that stretching cannot fix), and a pattern of OA development earlier than expected in your family. GDF5 determines your baseline joint vulnerability, and stiffness is the early warning sign.